Separation of immature granules containing color dye from the rat parotid gland

Parotid acinar cell contains many secretory granules. Most of granules are mature, but only little immature granules are included. These immature granules are not enough for investigation of granule maturation. In this study, we show an easy method of separation of immature granules from the rat parotid gland. In addition, we succeeded in detection of color dye in the granules. These results suggest that secretory granules can be visualized through endocytosis

The thiol-oxidizing agent diamide reduces isoproterenolstimulated amylase release in rat parotid acinar cells

In parotid acinar cells, activation of β-adrenergic receptors provokes exocytotic amylase release via the accumulation of intracellular cAMP. Cellular redox status plays a pivotal role in the regulation of various cellular functions. Cellular redox imbalance caused by the oxidation of cellular antioxidants, as a result of oxidative stress, induces significant biological damages. In this study, we examined effect of diamide, a thioloxidizing reagent, on amylase release in rat parotid acinar cells. In the presence of diamide, isoproterenol (IPR)-induced cAMP formation and amylase release were partially reduced. Diamide had no effect on amylase release induced by forskolin and mastoparan, an adenylate cyclase activator and heterotrimeric GTP binding protein activator, respectively. In the cells pretreated with diamide, the binding affinity of [3H]dihydroalprenolol to β-receptors was reduced. These results suggest that oxidative stress results in reduction of binding affinity of ligand on β-receptor and consequently reduces protein secretory function in rat parotid acinar cells

Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer

This report summarizes the presentations and discussion in the first Japan Clinical Oncology Group-European Organisation for Research and Treatment of Cancer Quality of Life/Patient-Reported Outcome workshop funded by the National Cancer Center Hospital that was held on Saturday, 1 September 2018 in Tokyo, Japan. The infrastructure and understanding regarding the Quality of Life/Patient-Reported Outcome assessment of cancer patients in Japan is still immature, in spite of the increased demand for oncological Patient-Reported Outcome research felt not only by researchers but also by patients or other stakeholders of cancer drug development. The workshop aimed to share each perspective, common issues to be considered and future perspectives regarding the strong alliance between the European Organisation for Research and Treatment of Cancer Quality of Life Group and the Japan Clinical Oncology Group for Quality of Life/Patient-Reported Outcome research as well as explore the possibility of conducting collaborative research. European Organisation for Research and Treatment of Cancer is a leading international cancer clinical trials organization, and its Quality of Life Group is a global leader in the implementation of Quality of Life research in cancer patients. The three invited speakers from the European Organisation for Research and Treatment of Cancer Quality of Life Group presented their perspective, latest methodology and ongoing projects. The three speakers from the Japan Clinical Oncology Group presented their current status, experience and some issues regarding data management or interpretation of the Patient-Reported Outcome data. The two patient advocates also shared their expectations in terms of advances in cancer research based on the Patient-Reported Outcome assessment. As the next steps after this workshop, the Japan Clinical Oncology Group and European Organisation for Research and Treatment of Cancer have decided to cooperate more closely to facilitate Patient-Reported Outcome research in both the groups, and the Japan Clinical Oncology Group has approved the establishment of a new committee for Quality of Life/Patient-Reported Outcome research in Japan

Zmiany perspektywy postrzegania czasu jako skutek psychoterapii

Constructed for clinical use and based on the concept of the feedback and feedforward systems in “cybernetic-psychology,” the Time Perspective Scale (TPS) was administered to three clients in order to assess the effects of psychotherapy. Two clients were withdrawn, suffering from a condition known as hikikomori in Japan; the other client was diagnosed with PTSD after suffering a major personal loss as a result of the Eastern Japan earthquake and tsunami in 2011. The TPS was administered at pre-, mid-, and post-interventions. In addition, the Hildreth Feeling-Attitude Scale (F-A Scale) and the Kumamoto University Competence Scale (KUCS) were also administered to compare the results of the TPS. Results from the TPS indicated that at the end of the intervention, clients’ thoughts were positively focused on the present and the future. In comparison to their negative thoughts concerning the present and the future during the pre-intervention period, two clients displayed positive feedback regarding the past, and all clients displayed positive thoughts about the present as well as positive feedforward thoughts for the future. Similar to the TPS, the F-A Scale and the KUCS indicated that the clients had more positive and more constructive cognitions after the intervention. Therefore, the TPS is a useful questionnaire for assessing the therapeutic efficacy of the time perspective